Ianalumab (Anti-TNFRSF13C / BAFFR / CD268)

Ask supplier a question | View on supplier's website

Ianalumab (Anti-TNFRSF13C / BAFFR / CD268) is a fully human combinatorial antibody library (HuCAL)-derived monoclonal antibody targeting the B-cell-activating factor receptor (BAFF-R), with potential anti-inflammatory and antineoplastic activities. MW : 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2329
Sku #	A2329-1mg*25
Pricing	1mg*25, $2370.00

Feedback